Brevan Howard Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$957K Buy
205,024
+12,748
+7% +$59.5K 0.01% 997
2025
Q1
$1.06M Buy
+192,276
New +$1.06M 0.01% 438